Some 2017 publications using MonolixSuite from the US National Library of Medecine/ National Institues of Health

Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal Anesthesia.
Djerada Z, Feliu C, Cazaubon Y, Smati F, Gomis P, Guerrot D, Charbit B, Fernandes O, Malinovsky JM.
Clin Pharmacokinet. 2017 Dec 13. doi: 10.1007/s40262-017-0617-2.
PMID: 29236228

Population pharmacokinetics of articaine with 1:200,000 epinephrine during third molar surgery and simulation of high-dose regimens.
Cazaubon Y, Mauprivez C, Feliu C, Binet L, Oget O, Gozalo C, Djerada Z.
Eur J Pharm Sci. 2017 Nov 29;114:38-45. doi: 10.1016/j.ejps.2017.11.027.
PMID: 29197630

Leishmanicidal candidate LASSBio-1736, a cysteine protease inhibitor with favorable pharmacokinetics: low clearance and good distribution.
Moraes BS, Azeredo FJ, Izoton JC, Amaral M, Barreiro EJ, Freddo RJ, Dalla Costa T, Lima LM, Haas SE.
Xenobiotica. 2017 Nov 21:1-32. doi: 10.1080/00498254.2017.1405465.
PMID: 29160126

Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children.
Béranger A, Oualha M, Urien S, Genuini M, Renolleau S, Aboura R, Hirt D, Heilbronner C, Toubiana J, Tréluyer JM, Benaboud S.
Clin Pharmacokinet. 2017 Oct 4. doi: 10.1007/s40262-017-0602-9.
PMID: 28980166

Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation.
Danielak D, Twardosz J, Kasprzyk A, Wachowiak J, Kałwak K, Główka F.
Eur J Clin Pharmacol. 2017 Oct 3. doi: 10.1007/s00228-017-2344-x.
PMID: 28975382

Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination Therapy.
Peigné S, Chhun S, Tod M, Rey E, Rodrigues C, Chiron C, Pons G, Jullien V.
Clin Pharmacokinet. 2017 Aug 17. doi: 10.1007/s40262-017-0592-7.
PMID: 28819726

Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.
Rodrigues C, Chiron C, Rey E, Dulac O, Comets E, Pons G, Jullien V.
Br J Clin Pharmacol. 2017 Dec;83(12):2695-2708. doi: 10.1111/bcp.13392.
PMID: 28771787

Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial.
Flicoteaux R, Protopopescu C, Tibi A, Blanchon T, Werf SV, Duval X, Mosnier A, Charlois-Ou C, Lina B, Leport C, Chevret S.
BMJ Open. 2017 Jul 10;7(7):e014546. doi: 10.1136/bmjopen-2016-014546.
PMID: 28698321

Population Approach to Efavirenz Therapy.
Duarte H, Cruz JP, Aniceto N, Ribeiro AC, Fernandes A, Paixão P, Antunes F, Morais J.
J Pharm Sci. 2017 Oct;106(10):3161-3166. doi: 10.1016/j.xphs.2017.06.004.
PMID: 28622951

First plasma and tissue pharmacokinetic study of the YSNSG cyclopeptide, a new integrin antagonist, using microdialysis.
Slimano F, Djerada Z, Bouchene S, Van Gulick L, Brassart-Pasco S, Dukic S.
Eur J Pharm Sci. 2017 Jul 15;105:178-187. doi: 10.1016/j.ejps.2017.05.016.
PMID: 28512055

A pharmacodynamic modelling and simulation study identifying gender differences of daily olanzapine dose and dopamine D2-receptor occupancy.
Eugene AR, Masiak J.
Nord J Psychiatry. 2017 Aug;71(6):417-424. doi: 10.1080/08039488.2017.1314011.
PMID: 28486094

Age-structured population model of cell survival.
Krzyzanski W, Wiczling P, Gebre A.
J Pharmacokinet Pharmacodyn. 2017 Aug;44(4):305-316. doi: 10.1007/s10928-017-9520-6.
PMID: 28357630

Population Pharmacokinetics of Gemcitabine and dFdU in Pancreatic Cancer Patients Using an Optimal Design, Sparse Sampling Approach.
Serdjebi C, Gattacceca F, Seitz JF, Fein F, Gagnière J, François E, Abakar-Mahamat A, Deplanque G, Rachid M, Lacarelle B, Ciccolini J, Dahan L.
Ther Drug Monit. 2017 Jun;39(3):290-296. doi: 10.1097/FTD.0000000000000399.
PMID: 28346313

Population pharmacokinetic modelling of valproic acid and its selected metabolites in acute VPA poisoning.
Jawień W, Wilimowska J, Kłys M, Piekoszewski W.
Pharmacol Rep. 2017 Apr;69(2):340-349. doi: 10.1016/j.pharep.2016.12.003.
PMID: 28187395

Metoprolol Dose Equivalence in Adult Men and Women Based on Gender Differences: Pharmacokinetic Modeling and Simulations.
Eugene AR.
Med Sci (Basel). 2016;4(4). pii: 18. doi: 10.3390/medsci4040018.
PMID: 28035289

Pharmacokinetic/pharmacodynamic modeling of etoposide tumor growth inhibitory effect in Walker-256 tumor-bearing rat model using free intratumoral drug concentrations.
Pigatto MC, Roman RM, Carrara L, Buffon A, Magni P, Dalla Costa T.
Eur J Pharm Sci. 2017 Jan 15;97:70-78. doi: 10.1016/j.ejps.2016.10.038.
PMID: 27816627

Some 2017 publications using MonolixSuite in CPT: Pharmacometrics & Systems Pharmacology

Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non‐Small Cell Lung Carcinoma
Diane‐Charlotte Imbs, Raouf El Cheikh, Arnaud Boyer, Joseph Ciccolini, Céline Mascaux, Bruno Lacarelle, Fabrice Barlesi, Dominique Barbolosi, Sébastien Benzekry
CPT Pharmacometrics Syst. Pharmacol.(2017) doi:10.1002/psp4.12265;

PharmML in Action: an Interoperable Language for Modeling and Simulation
Authors: R Bizzotto, E Comets, G Smith, F Yvon, NR Kristensen, MJ Swat
CPT Pharmacometrics Syst. Pharmacol.(2017)6, 651–665; doi:10.1002/psp4.12213;

Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation
B Ribba, HP Grimm, B Agoram, MR Davies, K Gadkar, S Niederer, N van Riel, J Timmis, PH van der Graaf
CPT Pharmacometrics Syst. Pharmacol.(2017)6, 496–498; doi:10.1002/psp4.12206;

Population Modeling of Selexipag Pharmacokinetics and Clinical Response Parameters in Patients With Pulmonary Arterial Hypertension
A Krause, M Machacek, D Lott, N Hurst, S Bruderer, J Dingemanse
CPT Pharmacometrics Syst. Pharmacol.(2017)6, 477–485; doi:10.1002/psp4.12202;

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics
T. H. T. Nguyen, M‐S Mouksassi, N Holford, N Al‐Huniti, I Freedman, A. C. Hooker, J. John, M. O. Karlsson, D. R. Mould, J. J. Pérez Ruixo, E. L. Plan, R Savic, J. G. C. van Hasselt, B Weber, C Zhou, E Comets, F Mentré, for the Model Evaluation Group of the International Society of Pharmacometrics (ISoP) Best Practice Committee
CPT Pharmacometrics Syst. Pharmacol.(2017)6, 87–109; doi:10.1002/psp4.12161;

Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic Drugs
LG Hutchinson, H‐J Mueller, EA Gaffney, PK Maini, J Wagg, A Phipps, C Boetsch, HM Byrne, B Ribba
CPT Pharmacometrics Syst. Pharmacol.(2016)5, 636–645; doi:10.1002/psp4.12142;

Exploratory Population PK Analysis of Dupilumab, a Fully Human Monoclonal Antibody Against IL‐4Rα, in Atopic Dermatitis Patients and Normal Volunteers
P Kovalenko, AT DiCioccio, JD Davis, M Li, M Ardeleanu, NMH Graham, R Soltys
CPT Pharmacometrics Syst. Pharmacol.(2016)5, 617–624; doi:10.1002/psp4.12136;